Maquet will distribute “a range” of Biotronik products designed to treat peripheral artery disease, including its Astron iliac self-expanding stent, Passeo percutaneous transluminal angioplasty balloon products and the line of Fortress reinforced sheaths, the companies said.
“Peripheral artery disease is a serious condition that can lead to amputations. Because the global prevalence of this disease is increasing, the need for innovative endovascular devices with which to treat patients is growing. Partnering with Biotronik allows us to enhance our current product offerings and expand our existing portfolio of vascular grafts and patches. With the addition of Biotronik’s innovative product line, we can now provide PAD patients in the United States and the vascular surgeons who treat them with a complete range of technically-advanced, high-quality endovascular devices,” Getinge Grouop Americas prez Raoul Quintero said in a prepared statement.
Wayne, N.J.-based Maquet said it will begin distribution of the products during the 1st quarter of this year.
“We are pleased to partner with Maquet to make our proven vascular intervention products available to patients and physicians inthe United States. Maquet is a highly-regarded medical device company that has a wealth of experience marketing innovative technology to clinicians. This partnership will ensure that our peripheral vascular product line, including our newly approved Astron iliac stent, will now benefit patients in the United States,” Biotronik prez Marlou Janssen said in a press release.
Last week, Biotronik said it won CE Mark approval in the European Union for smaller sizes of its Passeo-18 Lux drug-coated balloon designed for treating peripheral arterial disease, specifically de novo and restenotic lesions in the infrainguinal arteries.
The device is now cleared in 2 mm and 2.5 mm sizes to facilitate treatment of below-the-knee arteries